Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2005
08/17/2005EP1562620A2 Modified cytokines for use in cancer therapy
08/17/2005EP1562587A2 Novel compositions and methods for the treatment of immune related diseases
08/17/2005EP1519979A4 Poly-gamma-glutamate having ultra high molecular weight and method for using the same
08/17/2005EP1466174A4 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
08/17/2005EP1461445A4 Glycoprotein remodeling using endoglycanases
08/17/2005EP1427830A4 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
08/17/2005EP1419392A4 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs
08/17/2005EP1411761A4 Metabolite transporters
08/17/2005EP1224473B1 Method for the determination of autoantibodies raised against the tsh receptor
08/17/2005EP1224215B1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE
08/17/2005EP1161250B1 Immunostimulant bacterial membrane fractions in cancer treatment
08/17/2005EP1109908B1 Methods for determining compounds for modulating the body weight
08/17/2005EP1066372B1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same
08/17/2005EP1051500B1 Diagnosis and treatment of aur1 and/or aur2 related disorders
08/17/2005EP1049767B1 A transgenic rabbit that expresses a functional human lipoprotein (a)
08/17/2005EP1023445B1 Cadherin derived growth factor and the application thereof
08/17/2005EP0994955B1 Increased production of secreted proteins by recombinant yeast cells
08/17/2005EP0984983B1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain
08/17/2005EP0975674B1 Immunotoxins, comprising an onc protein, directed against malignant cells
08/17/2005EP0939804B1 NEUTROKINE alpha
08/17/2005EP0837880B1 Enamel matrix related polypeptide
08/17/2005EP0836618B1 Radiometal-binding analogues of leutenizing hormone releasing hormone
08/17/2005EP0833917B1 Malarial pre-erythrocytic stage polypeptide molecules
08/17/2005EP0832189B1 Process for controlling sialylation of proteins produced by mammalian cell culture
08/17/2005EP0784633B1 Process for purifying factor viii
08/17/2005EP0760671B1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
08/17/2005EP0742826B1 Multivariant il-3 hematopoiesis fusion protein
08/17/2005EP0731844B1 Promoter
08/17/2005EP0636172B1 Genetically engineered attenuated viruses
08/17/2005CN1656237A Antiviral inhibition of capsid proteins
08/17/2005CN1656223A Bone generation by gene therapy
08/17/2005CN1656119A Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases
08/17/2005CN1656118A Human 5-HT7 receptor promoter sequence
08/17/2005CN1656117A Use of the repressor glxR for the synthesis of lysine in corynebacterium glutamicum
08/17/2005CN1656116A Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the HPV-16 virus
08/17/2005CN1656115A Gamma-secretase inhibitors
08/17/2005CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof
08/17/2005CN1655827A Novel use of adenoviruses and nucleic acids coding therefor
08/17/2005CN1655804A Method and composition for treating cardiovascular diseases by employing neuroregulation protein
08/17/2005CN1654657A Novel streptococcus antigens
08/17/2005CN1654656A FenneropenaeusChinensis Crustin gene and coded protein and cloning method therefor
08/17/2005CN1654655A Cloning of full-length cDNA of Camptotheca acuminata anti-drought gene caGRP
08/17/2005CN1654653A Novel natural antibacterial peptide HKABF and its preparation and application
08/17/2005CN1654652A Amphioxus dimethyl arginine hydrolase AmphiDDAH gene and its application
08/17/2005CN1654651A Novel natural antibacterial peptide Hippocampusin and its preparation and application
08/17/2005CN1654634A Microorganism producing l-threonine, method of producing the same and method of producing l-threonine using the microorganism
08/17/2005CN1654624A Microorganism producing l-threonine, method of producing the same and method of producing l-threonine using the microorganism
08/17/2005CN1654478A Method for preparing polyethylene glycol-modified alpha-interferon 1b
08/17/2005CN1654477A Process for preparing transfer factor-heating method
08/17/2005CN1654475A Preparation and use of conservative region of recombinant helicobacter pylori adhesin
08/17/2005CN1654474A 重组幽门螺杆菌热休克蛋白60 Recombinant H. pylori heat shock protein 60
08/17/2005CN1654472A Recombinant helicobacter pylori outer-membrane protein 25
08/17/2005CN1654471A Recombinant helicobacter pylori blood group antigen adhesin
08/17/2005CN1654470A Recombinant helicobacter pylori outer-membrane protein 15
08/17/2005CN1215171C Process for preparing truncated recombinant human bone morphorgenetic protein-2 mature peptide
08/17/2005CN1215167C Helicobacter pylori live vaccine
08/17/2005CN1215082C Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
08/16/2005US6930225 Adjusting concentration of cellulose synthase in plants; genetic engineering
08/16/2005US6930223 Genetic engineering; modifying the fibre, starch, nitrogen, non-sulfur containing amino acid, anti-nutritional protein, and/or fatty acid content and/or composition in mono-/dicotylendonous plants
08/16/2005US6930181 a neuroendocrine protein antigen associated with Type I diabetes mellitus, nucleic acid encoding the protein and methods and reagents for detecting antibody against the protein and identifying individuals at risk of developing Type I diabetes
08/16/2005US6930180 Mutant protein for use as tool in genetic engineering
08/16/2005US6930176 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
08/16/2005US6930175 Gene family with transformation modulating activity
08/16/2005US6930174 CCR5 chemokine receptor-specific antibodies
08/16/2005US6930172 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/16/2005US6930171 Rhamnose binding protein
08/16/2005US6930169 Reducing induced apoptosis; obtain sample, incubate with modulator, monitor sample for reduction in apoptitic activity
08/16/2005US6930168 Synthetic peptides to treat an autoimmune demylinating disease e.g., multiple sclerosis; an amino acid sequence having two tyrosine residues and a lysine complex with the myelin basic proteing to modulate an immune response
08/16/2005US6930167 DNA encoding bovine immunoglobulin a inducing protein and uses therefor
08/16/2005US6930095 For use in anti-viral drug screening, and vaccine development
08/16/2005US6930090 Methods of activating a receptor using amphiphilic drug-oligomer conjugates
08/16/2005US6930088 Conformationally constrained backbone cyclized somatostatin analogs
08/16/2005US6930086 Erythropoietin mutein for use in the treatment of anemia
08/16/2005US6930085 G-type peptides to ameliorate atherosclerosis
08/16/2005US6930084 Treating arthritis with TNF receptor releasing enzyme
08/16/2005US6929946 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
08/16/2005US6929941 Chimeric cell-targeting pathogenic organism and method of therapeutic use
08/16/2005US6929938 25501, a human transferase family member and uses therefor
08/16/2005US6929932 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing
08/16/2005US6929931 Expression contructs using Lactobacillus delbrueckii subsp. lactis lac repressor protein and its lac repressor binding site, microorganisms and methods thereof
08/16/2005US6929930 Nucleotide sequences coding antigenic peptide for use in diagnosis of bacterial infections
08/16/2005US6929924 eliminates all interference due to proinsulin and its intermediates, in particular des-31,32-proinsulin and/or des-64,65-proinsulin
08/16/2005US6929923 Modulators of leukocyte activation, BIC compositions and methods of use
08/16/2005US6929921 Antibody which binds human blue-light photoreceptor hCRY2
08/16/2005US6929919 Proteins related to schizophrenia and uses thereof
08/16/2005US6929916 Kits for use in the detection of preferential interactions between biopolymers
08/16/2005US6929913 Compositions and methods for regulating autolytic processes in bacteria
08/16/2005US6929910 Diagnostic and therapeutic methods using the H37 tumor suppressor gene
08/16/2005US6929796 Methods to treat undesirable immune responses
08/16/2005US6929795 Contacting a sample from the blood of a human or animal with the chimeric polypeptide and determining the presence of visceral Leishmaniosis by detection of binding between polypeptide and Leishmania infantum antibodies
08/16/2005US6929791 An antibody which binds to an interleukin-2 (IL-2) peptide of given amino acid sequence; vectors
08/16/2005CA2236164C Pulmonary surfactant peptide solubilization process
08/16/2005CA2224257C Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
08/16/2005CA2200119C Adsorbent for removing chemokine, method for removing the same, and adsorber for the same
08/16/2005CA2193323C Process for preparing a synthetic calibrator for use in sandwich immunoassays, which calibrator consists of an antibody against one of the antibodies used in the assay and of a sequence of the analyte
08/16/2005CA2098533C Carrier system against gnrh
08/16/2005CA2084075C The ciliary neurotrophic factor receptor
08/11/2005WO2005073730A1 Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 8 (mglur8)
08/11/2005WO2005073404A2 Functional element of siah-1b responsive p53
08/11/2005WO2005073402A1 Vesicle used to separate substances from liquid media